Skip to content
10-K

Annual Report

Nu Skin Enterprises, Inc. NUS

0001140361-25-004907

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 31, 2025 49.72M sh
Long Term Debt FY 2024 · Dec 31, 2023 $478.04M
Short Term Debt FY 2024 · Dec 31, 2023 $25M
Short Term Investments FY 2024 · Dec 31, 2023 $11.76M
Cash And Equivalents FY 2024 · Dec 31, 2023 $256.06M
Stockholders Equity FY 2024 · Dec 31, 2023 $821.97M
Current Liabilities FY 2024 · Dec 31, 2023 $328.87M
Total Liabilities restated FY 2024 · Dec 31, 2023 $986.66M
Current Assets FY 2024 · Dec 31, 2023 $701.87M
Total Assets restated FY 2024 · Dec 31, 2023 $1.81B
Shares Diluted FY 2024 · Dec 31, 2022 50.53M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $70.05M
Dividends Paid FY 2024 · Dec 31, 2022 $77.02M
Capex FY 2024 · Dec 31, 2022 $59.06M
Operating Cash Flow FY 2024 · Dec 31, 2022 $108.06M
Eps Diluted FY 2024 · Dec 31, 2022 $2.07
Eps Basic FY 2024 · Dec 31, 2022 $2.10
Sga Expense FY 2024 · Dec 31, 2022 $555.77M
Rd Expense FY 2024 · Dec 31, 2022 $23.3M
Net Income FY 2024 · Dec 31, 2022 $104.78M
Operating Income FY 2024 · Dec 31, 2022 $110.85M
Gross Profit FY 2024 · Dec 31, 2022 $1.59B
Cost Of Revenue FY 2024 · Dec 31, 2022 $630.92M
Revenue FY 2024 · Dec 31, 2022 $2.23B